Net revenues of Pfizer Inc
Pfizer Inc Net Revenues 1999-2018
Amounts are in $millions.
| Year | Net Revenues ($m) |
| 2018 | $ 53,647 |
| 2017 | $ 52,546 |
| 2016 | $ 52,824 |
| 2015 | $ 48,851 |
| 2014 | $ 49,605 |
| 2013 | $ 51,584 |
| 2012 | $ 54,657 |
| 2011 | $ 61,035 |
| 2010 | $ 61,591 |
| 2009 | $ 46,314 |
| 2008 | $ 47,529 |
| 2007 | $ 47,733 |
| 2006 | $ 48,371 |
| 2005 | $ 47,405 |
| 2004 | $ 48,988 |
| 2003 | $ 41,787 |
| 2002 | $ 29,758 |
| 2001 | $ 26,593 |
| 2000 | $ 25,958 |
| 1999 | $ 26,940 |
Pfizer Inc. is a research-based, global biopharmaceutical company. The global portfolio of Pfizer includes medicines and vaccines, as well as many of the world’s best-known consumer healthcare products. The company operates in developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. It collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. The revenues of Pfizer are derived from the sale of our products and, to a much lesser extent, from alliance agreements, under which we co-promote products discovered or developed by other companies or us . The majority of Pfizer's revenues come from the manufacture and sale of biopharmaceutical products. The Company was incorporated under the laws of the State of Delaware on June 2, 1942.
The Net revenues of Pfizer Inc grew to $53.65 billion in 2018 from $52.55 billlion in 2017.